Radiopharmaceutical developer North American Scientific reported second-quarter net sales of $2.9 million, down 42% from the $5 million booked in the second quarter of 2002. For the period (end-April 30), the Chatsworth, CA-based firm had a net loss of $2.4 million, compared with a net loss of $4.9 million (including $4.6 million of write-downs) in the same period a year ago.
NAS had expected the dip in sales, which it attributed to the transition from an exclusive distribution relationship to direct sales. However, the company said it was pleased with the sales momentum for its Prospera Pd-103 and Prospera I-125 brachytherapy seeds.
By AuntMinnie.com staff writersMay 22, 2003
Related Reading
NAS resubmits IND, May 9, 2003
NAS shows sales uptick, February 25, 2003
Theseus in co-development deal with NCI, February 18, 2003
Theseus withdraws IND application, January 21, 2003
NAS begins direct sales of brachytherapy seeds, posts year-end results, December 17, 2002
Copyright © 2003 AuntMinnie.com
